Literature DB >> 19691479

Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X.

L Yang1, C Manithody, A R Rezaie.   

Abstract

BACKGROUND: There are two O-linked and two N-linked glycosylation sites on the activation peptide of factor X (FX) involving residues Thr-17, Thr-29, Asn-39 and Asn-49.
OBJECTIVES: The purpose of this study was to explore the contribution of carbohydrates of the FX activation peptide to zymogen recognition by physiological activators.
METHODS: The putative glycosylation sites were substituted individually or in combinations with Ala and mutants were expressed in mammalian cells. The entire activation peptide up to the P3 residue was deleted in another construct.
RESULTS: It was discovered that activation of zymogen mutants by both FVIIa and FIXa on negatively charged phospholipid vesicles has been improved 2-40-fold independent of a cofactor. These mutants were activated with slightly lower catalytic efficiency (k(cat)/K(m)) by FVIIa in the extrinsic Xase complex, though both K(m) and k(cat) constants for mutants were elevated. With the exception of approximately 3-fold improvement in the activation of N49A, the catalytic efficiency of FIXa toward mutants was decreased 2-5-fold in the intrinsic Xase complex.
CONCLUSIONS: The carbohydrate chains of the FX activation peptide play an important role in restricting the specificity of zymogen recognition by both FVIIa and FIXa, thereby preventing the cofactor-independent activation of FX by these proteases. On the other hand, the carbohydrates contribute to the cofactor-dependent recognition of the zymogen by both extrinsic and intrinsic Xase complexes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691479      PMCID: PMC2752496          DOI: 10.1111/j.1538-7836.2009.03578.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  25 in total

1.  Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.

Authors:  Lin Chen; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

Review 2.  The coagulation cascade: initiation, maintenance, and regulation.

Authors:  E W Davie; K Fujikawa; W Kisiel
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

Review 3.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.

Authors:  K G Mann; R J Jenny; S Krishnaswamy
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C.

Authors:  S P Leytus; D C Foster; K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1986-09-09       Impact factor: 3.162

5.  Exosite interactions determine the affinity of factor X for the extrinsic Xase complex.

Authors:  R J Baugh; C D Dickinson; W Ruf; S Krishnaswamy
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

6.  Role of basic residues of the autolysis loop in the catalytic function of factor Xa.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

7.  Exosite-dependent regulation of factor VIIIa by activated protein C.

Authors:  Chandrashekhara Manithody; Philip J Fay; Alireza R Rezaie
Journal:  Blood       Date:  2003-02-20       Impact factor: 22.113

8.  Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.

Authors:  P Fuentes-Prior; Y Iwanaga; R Huber; R Pagila; G Rumennik; M Seto; J Morser; D R Light; W Bode
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

Review 9.  Structure-function relationships in factor IX and factor IXa.

Authors:  Amy E Schmidt; S Paul Bajaj
Journal:  Trends Cardiovasc Med       Date:  2003-01       Impact factor: 6.677

10.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

View more
  7 in total

1.  Mass spectrometry based analysis of human plasma-derived factor X revealed novel post-translational modifications.

Authors:  Guillaume Chevreux; Nolwenn Tilly; Valegh Faid; Nicolas Bihoreau
Journal:  Protein Sci       Date:  2015-09-18       Impact factor: 6.725

2.  Carbohydrates and activity of natural and recombinant tissue factor.

Authors:  Jolanta Krudysz-Amblo; Mark E Jennings; Kenneth G Mann; Saulius Butenas
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

3.  The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.

Authors:  Qiulan Ding; Yiping Shen; Likui Yang; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

4.  Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.

Authors:  Qiuya Lu; Likui Yang; Chandrashekhara Manithody; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Res       Date:  2014-08-20       Impact factor: 3.944

Review 5.  Procoagulant adaptation of a blood coagulation prothrombinase-like enzyme complex in australian elapid venom.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  Toxins (Basel)       Date:  2010-06-18       Impact factor: 4.546

6.  In vivo analysis of the role of O-glycosylations of von Willebrand factor.

Authors:  Idinath Badirou; Mohamad Kurdi; Paulette Legendre; Julie Rayes; Marijke Bryckaert; Caterina Casari; Peter J Lenting; Olivier D Christophe; Cecile V Denis
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

7.  Role of the activation peptide in the mechanism of protein C activation.

Authors:  Bosko M Stojanovski; Leslie A Pelc; Enrico Di Cera
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.